Implementation of a Clinical Screening and Response System for Cardiac Complications After Noncardiac Surgery

Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · May 11, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new system designed to detect heart problems early in patients who are at risk and are undergoing non-heart-related surgeries. The goal is to see if this system can effectively identify cardiac complications, such as heart injury or heart attack, after surgery, and to understand the benefits and costs associated with using it. The researchers also want to find out what challenges they might face when implementing this system and gather information that could lead to a more extensive study in the future.

To participate in this trial, patients need to be between 40 and 85 years old, have an increased risk for heart issues, and be scheduled for certain types of surgeries, such as orthopedic or vascular procedures, where they will stay in the hospital for at least two nights. Patients who have had recent heart surgery or have certain medical conditions, like severe dementia or kidney failure requiring dialysis, will not be eligible. If a patient joins the study, they can expect to be part of a system that aims to improve their care and safety during and after their surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Consecutive patients fulfilling the institutional criteria for inclusion into the routine PMI-screening
• • aged 40-85 years
• • at increased cardiovascular risk
• • undergoing inpatient, noncardiac, elective or emergent surgery
• • postoperative stay of ≥2 nights at the participating institution
• • orthopaedic, traumatology, vascular, spinal, thoracic, neurosurgical, and visceral surgery.
• Exclusion Criteria:
• • patients with cardiac surgery or interventions in the last 14 days
• • chronic renal failure under dialysis, renal transplant surgery
• • moderate-to-severe dementia
• • previous inclusion within 5 days
• • documented refusal to use of their data for research purposes or refusal of further use during follow-up
• • Patients declining consent for follow-up will be excluded from follow-up analyses.